Reviewing Sintx Technologies (NASDAQ:SINT) and LENSAR (NASDAQ:LNSR)

Sintx Technologies (NASDAQ:SINT – Get Free Report) and LENSAR (NASDAQ:LNSR – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, institutional ownership and dividends.

Valuation & Earnings

This table compares Sintx Technologies and LENSAR”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sintx Technologies $1.02 million 9.97 -$10.36 million ($1.69) -0.80
LENSAR $58.44 million 1.05 -$34.28 million ($0.40) -12.50

Sintx Technologies has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Sintx Technologies and LENSAR, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sintx Technologies 1 0 3 0 2.50
LENSAR 1 0 2 0 2.33

Sintx Technologies currently has a consensus target price of $9.50, indicating a potential upside of 606.32%. LENSAR has a consensus target price of $11.00, indicating a potential upside of 120.00%. Given Sintx Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe Sintx Technologies is more favorable than LENSAR.

Institutional and Insider Ownership

18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 40.1% of LENSAR shares are held by institutional investors. 8.1% of Sintx Technologies shares are held by insiders. Comparatively, 65.8% of LENSAR shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Sintx Technologies and LENSAR’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sintx Technologies -281.91% -309.86% -101.90%
LENSAR 56.07% 1,254.25% 49.13%

Summary

LENSAR beats Sintx Technologies on 7 of the 13 factors compared between the two stocks.

About Sintx Technologies

(Get Free Report)

SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced materials company focused on the development, manufacturing and commercialization of silicon nitride-based ceramics. The company’s technology is designed to combine properties such as biocompatibility, strength, wear resistance and antimicrobial performance for use in medical and other demanding applications. In its medical business, SINTX develops silicon nitride products for spinal, orthopedic and dental applications, including implant materials, components and coatings.

About LENSAR

(Get Free Report)

LENSAR, Inc. develops and markets laser-based technology for ophthalmic surgery, with a focus on procedures used to treat cataracts. Its systems are designed to assist surgeons with key steps in cataract surgery, including the creation of incisions and the fragmentation of the eye’s natural lens. The company’s products include the ALLY Adaptive Cataract Treatment System and the LENSAR Laser System, which use imaging and software to support surgical planning and treatment. LENSAR also offers related software, accessories and services for ophthalmic practices and surgical facilities.

Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.